Coherus Oncology, Inc. (CHRS)
NASDAQ: CHRS · Real-Time Price · USD
1.410
-0.050 (-3.42%)
At close: Aug 28, 2026, 4:00 PM EDT
1.390
-0.020 (-1.42%)
After-hours: Aug 28, 2026, 7:49 PM EDT
Coherus Oncology Market Cap
Coherus Oncology has a market cap or net worth of $217.85 million as of August 28, 2026. Its market cap has increased by 64.41% in one year.
Market Cap
217.85M
Enterprise Value
166.72M
1-Year Change
64.41%
Ranking
Category
Stock Price
$1.41
ChartMarket Cap Chart
Since November 6, 2014, Coherus Oncology's market cap has decreased from $404.20M to $217.85M, a decrease of -46.10%. That is a compound annual growth rate of -5.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 217.80M | 26.92% |
| Dec 31, 2025 | 171.60M | 7.92% |
| Dec 31, 2024 | 159.00M | -57.12% |
| Dec 29, 2023 | 370.80M | -39.81% |
| Dec 30, 2022 | 616.00M | -49.73% |
| Dec 31, 2021 | 1.23B | -2.13% |
| Dec 31, 2020 | 1.25B | -0.83% |
| Dec 31, 2019 | 1.26B | 105.12% |
| Dec 31, 2018 | 615.60M | 20.73% |
| Dec 29, 2017 | 509.90M | -58.50% |
| Dec 30, 2016 | 1.23B | 37.60% |
| Dec 31, 2015 | 893.00M | 64.52% |
| Dec 31, 2014 | 542.80M | 34.29% |
| Nov 6, 2014 | 404.20M | - |
View and export this data all the way back to 2014. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 225.74M |
| Sol-Gel Technologies | 225.28M |
| Keros Therapeutics | 218.69M |
| Voyager Therapeutics | 218.13M |
| Precision BioSciences | 214.74M |
| NovaBridge Biosciences | 213.44M |
| PepGen | 213.32M |
| Acumen Pharmaceuticals | 211.17M |